Cargando…
CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study
Background. Genetic polymorphisms of drug metabolizing enzymes involved in the detoxification pathways of carcinogenic substances may influence cancer risk. Methods. Case-control study that investigates the relationship between CYP1A1 Ile/Val, exon 4 mEH, and GSTM1 null genetic polymorphism and the...
Autores principales: | Varela-Lema, L., Ruano-Ravina, A., Juiz Crespo, M. A., Kelsey, K. T., Loidi, L., Barros-Dios, J. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648631/ https://www.ncbi.nlm.nih.gov/pubmed/19259333 http://dx.doi.org/10.1155/2008/741310 |
Ejemplares similares
-
Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma
por: Khedhaier, Achraf, et al.
Publicado: (2008) -
mEH Tyr113His polymorphism and the risk of ovarian cancer development
por: Zhong, Jian-Hong, et al.
Publicado: (2013) -
Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids
por: Marowsky, Anne, et al.
Publicado: (2017) -
Evidence for a complex formation between CYP2J5 and mEH in living cells by FRET analysis of membrane protein interaction in the endoplasmic reticulum (FAMPIR)
por: Orjuela Leon, Anette Carolina, et al.
Publicado: (2017) -
Polymorphisms of CYP1A1 and GSTM1 Genes and Susceptibility to Oral Cancer
por: Cha, In-Ho, et al.
Publicado: (2007)